Site-specific proportion cured models applied to cancer registry data
- 193 Downloads
Proportion-cured models were applied to evaluate their applicability on data from a relatively small cancer registry and to assess the up-to-date survival level of major cancer types in Tyrol, Austria.
In total, the 25 most common types of cancer were analyzed with mixture cure models using the period approach for estimation of the proportion cured and median survival time of the fatal cases.
For several of the cancer types, no estimates could be obtained. The models converged for 14 sites among females and for 15 among males. The highest estimate of the proportion cured was found for cervix cancer (74.0 %; 95 % CI 64.4–83.6) and the lowest for male pancreas cancer (4.6 %; 95 % CI 0.2–9.0). The highest median survival of the uncured was 2.7 years (95 % CI 1.2–6.0) for male larynx cancer and the lowest 0.3 years (95 % CI 0.1–0.6) for male acute myeloblastic leukemia (AML).
The estimates seem reliable for stomach, colon, rectum, pancreas, lung, cervix, ovary, central nervous system/brain and AML cancer and among men also for head/neck, esophagus, liver and kidney cancer. Altogether, it is demonstrated that even data from a regional cancer registry covering a rather small region can be utilized to derive up-to-date survival estimates of various cancer types, enabling monitoring of the development and changes in cancer treatment. Moreover, potentially this methodology is advantageously employable in any situation where the number of cancer cases is limited.
KeywordsSite-specific cancer survival Proportion cured Survival time uncured Cancer registry Epidemiology
Acute lymphoblastic leukemia
Acute myeloblastic leukemia
Chronic lymphoid leukemia
Central nervous system
Non-melanoma skin cancer
We thank Lois Harrasser sincerely for his good work managing the data.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.World Health Organisation (2008) The global burden of disease: 2004 update. World Health Organisation, Geneva, 146 pGoogle Scholar
- 7.Oberaigner W, Mühlböck H, Harrasser L (2011) Tumorregister Tirol, Bericht für das Diagnosejahr 2009. Innsbruck, IET-Bericht, 118 pGoogle Scholar
- 9.Boniol M, Heanue M (2007) Age-standardisation and denominators. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) Cancer incidence in five continents, volume IX; IARC Scientific Publications No. 160. International Agency for Research on Cancer, Lyon, pp 99–101Google Scholar
- 11.Lambert PC (2007) Modeling of the cure fraction in survival studies. Stata J 7:1–25Google Scholar
- 22.Andersson TML, Lambert PC, Derolf ÅR, Kristinsson SY, Eloranta S, Landgren O, Björkholm M, Dickman PW (2009) Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973–2001, a population-based study. Br J Haematol 148:918–924CrossRefPubMedGoogle Scholar
- 26.Gatta G, Rossi S, Foschi R, Trama A, Marcos-Gragera R, Pastore G, Peris-Bonet R, Stiller C, Capocaccia R, EUROCARE Working Group (2013) Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. Haematologica 98:744–752CrossRefPubMedGoogle Scholar